Oxeia Biopharmaceuticals files Reg CF amendment correcting bonus-share perk date; DealMaker intermediary

Form type
Form C/A Reg CF amendment
Amount
Reg CF offering
Filed
2026-11-20
Platform
DealMaker Securities

Non-material amendment correcting typographical errors, including a date in the Time-Based Bonus Shares perk, and replacing Exhibit I; DealMaker Securities is the intermediary.

View filing on SEC EDGAR →

Opens the filing on sec.gov

Share this filing

Offering amounts are maximums, not money raised. Source: SEC EDGAR. © 2026 Crowded Media Group, LLC. All rights reserved.